Back

Single center experience of efficacy and safety of atrioventricular node ablation after left bundle branch area pacing for the management of atrial fibrillation

7 April 2024 (11:30 - 12:15)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: heart failure Rate Control EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Mathieu Jacobs

University Hospital of Tours, Tours (France)

7 More presentations in this session

Presentation thumbnail
Improvement in atrial functional and ventricular functional tricuspid regurgitation following catheter ablation or cardioversion of atrial fibrillation
Doctor B. Kuru Gorgulu (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Stroke after implantable cardioverter-defibrillator shocks in patients with heart failure
Mr M. Dyrbus (Zabrze, PL)
Abstract Slides Video
Presentation thumbnail
Newly diagnosed heart failure in patients with atrial fibrillation referred for catheter ablation - identifying patients with arrhythmia-induced cardiomyopathy
Doctor J. Riess (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Definition and management of arrhythmia-induced cardiomyopathy: findings from the EHRA SIC survey
Associate Professor P. Badertscher (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation
Mrs R. Arnet (Basel, CH)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: heart failure

The Event

Event poster

EHRA 2024

7 April 2024 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Effectiveness and safety of atrioventricular node ablation after his bundle pacing in patients with uncontrolled atrial arrhythmias: long-term results analysis
thumbnail
Congress Presentation
Conduction system pacing and atrioventricular node ablation for atrial fibrillation - a systematic review and meta-analysis
thumbnail
Congress Presentation
Impact of ablate and pace on clinical outcomes, quality of life and healthcare utilization in patients with atrial fibrillation